FDA clears Boston Scientific's carotid artery stent

10/23/2008 | Boston Globe (tiered subscription model), The

The FDA has granted approval for Boston Scientific's Carotis Wallstent Monorail Endoprosthesis, a stent designed to treat carotid artery disease in people at high risk for surgery. The device, which is already approved in Europe, can help lower the risk of stroke, a company official said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ